Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Verve Therapeutics Inc.

    NASDAQ: VERV · Real-Time Price · USD
    11.13
    0.03 (0.27%)
    At close: Jul 24, 2025, 3:59 PM

    Verve Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 32.33M 11.76M 1.94M n/a
    Cost of Revenue
    		 n/a n/a n/a 3.38M
    Gross Profit
    		 32.33M 11.76M 1.94M -3.38M
    Operating Income
    		 -228.66M -223.12M -165.69M -87.07M
    Interest Income
    		 n/a n/a 6.87M 142K
    Pretax Income
    		 -198.36M -199.79M -157.33M -120.31M
    Net Income
    		 -198.71M -200.07M -157.39M -118.64M
    Selling & General & Admin
    		 56.65M 49.94M 37.53M 18.86M
    Research & Development
    		 204.35M 184.95M 130.09M 68.2M
    Other Expenses
    		 n/a n/a 1.49M -33.39M
    Operating Expenses
    		 260.99M 234.88M 167.63M 87.07M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 260.99M 234.88M 167.63M 87.07M
    Income Tax Expense
    		 349K 275K 53K -1.68M
    Shares Outstanding (Basic)
    		 84.72M 64.18M 54.02M 48.51M
    Shares Outstanding (Diluted)
    		 84.72M 64.18M 54.02M 48.51M
    EPS (Basic)
    		 -2.36 -3.12 -2.91 -2.45
    EPS (Diluted)
    		 -2.35 -3.12 -2.91 -2.45
    EBITDA
    		 -221.91M -217.67M -162.88M -85.53M
    EBIT
    		 -228.66M -223.12M -165.69M -120.31M
    Depreciation & Amortization
    		 6.75M 5.46M 6.71M 3.38M

    Add to Watchlist